Evidence map›Paper›PMID 32547514›Full record

ArticleFrontiers in microbiology2020

Prolyl Oligopeptidase From

Camila Lasse, Clênia S Azevedo, Carla N de Araújo, Flávia N Motta, Milene A Andrade, Amanda Pereira Rocha, Iracyara Sampaio, Sébastien Charneau, Marc Gèze, Philippe Grellier and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Discovery ofFrontiers in pharmacology · 2022
    Article
  5. Three types ofFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Camila LassePathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Clênia S AzevedoPathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Carla N de AraújoPathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Flávia N MottaPathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Milene A AndradePathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Amanda Pereira RochaPathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Iracyara SampaioPathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Sébastien CharneauLaboratory of Protein Chemistry and Biochemistry, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Marc GèzeUMR 7245 MCAM, Musèum National d'Histoire Naturelle, Centre National de la Recherche Scientifique, Paris, France.
Philippe GrellierUMR 7245 MCAM, Musèum National d'Histoire Naturelle, Centre National de la Recherche Scientifique, Paris, France.
Jaime M SantanaPathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Izabela M D BastosPathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.
Universidade de Brasília · BRCentre National de la Recherche Scientifique · FRMuséum national d'Histoire naturelle · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug targetleishmaniasisPOPLiproteasevirulence factor

Identifiers

PMID32547514
PMCPMC7271538
OpenAlexW3029108166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.